Viscosupplementation Market 2027 By Course of Treatment, Anatomy, End User and Geography | The Insight Partners

Viscosupplementation Market to 2027 - Global Analysis and Forecasts By Course of Treatment (Single Injection, Multiple Injection); Anatomy (Knee Osteoarthritis, Hip Osteoarthritis, Ankle Osteoarthritis, Shoulder Osteoarthritis); End User (Hospitals, Clinics, Ambulatory Surgical Centers) and Geography

Report Code: TIPRE00006722 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
MARKET INTRODUCTION

Viscosupplementation is a method in which a thick fluid called hyaluronate is injected into the knee joint. There are no remedies for osteoarthritis, so viscosupplementation will not counteract osteoarthritis of the knee. However, it is claimed that hyaluronate helps in improving the lubricating properties of the synovial fluid, lessen the pain from osteoarthritis of the knee, improves mobility, and provide a higher and more convenient level of activity. Viscosupplementation is a minimally invasive procedure which involves injection of gel-like substance. Currently hyaluronate injections are only approved viscosupplementation therapy of osteoarthritis of the knee. Hyaluronic acid (HA) or hyaluronate is a non-sulfated glycosaminoglycan that is distributed throughout the body in epithelial, connective tissues, and neural tissues.


MARKET DYNAMICS

Viscosupplementation market is anticipated to grow in the forecast period owing to driving factors such as rising number of increasing geriatric population, increasing demand for minimally invasive surgical procedures, high patient awareness about new drugs. Moreover and devices for the treatment of osteoarthritis and rising obese population globally, rising investments by major players for the growing demand are also offering opportunities in the market growth during the forecast period.

MARKET SCOPE

The "Global Viscosupplementation Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of viscosupplementation market with detailed market segmentation by course of treatment, anatomy, end user, and geography. The global viscosupplementation market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading viscosupplementation market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global viscosupplementation market is segmented on the basis of course of treatment, anatomy and end user. Based on course of treatment, the market is segmented as Single Injection and multiple injection. Based on Anatomy, the market is segmented as Knee Osteoarthritis, Hip Osteoarthritis, Ankle Osteoarthritis and Shoulder Osteoarthritis. On the basis of end user, the global viscosupplementation market is segmented into hospitals, clinics, and ambulatory service centers.


REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global viscosupplementation market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The viscosupplementation market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting viscosupplementation market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the viscosupplementation market in these regions.


MARKET PLAYERS


The report covers key developments in the viscosupplementation market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from viscosupplementation market are anticipated to lucrative growth opportunities in the future with the rising demand for viscosupplementation in the global market. Below mentioned is the list of few companies engaged in the viscosupplementation market.

The report also includes the profiles of key viscosupplementation market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Bioventus Inc.
  •  Anika Therapeutics
  •  Seikagaku Corporation
  •  Zimmer Biomet
  •  Smith & Nephew PLC
  •  Ferring B.V.
  •  Lifecore Biomedical, LLC (Landec)
  •  Salix Pharmaceuticals
  •  Fidia Farmaceutici S.P.A
  •  LG Life Sciences Ltd.

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Viscosupplementation Market - By Course of Treatment
1.3.2 Viscosupplementation Market - By Anatomy
1.3.3 Viscosupplementation Market - By End User
1.3.4 Viscosupplementation Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. VISCOSUPPLEMENTATION MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. VISCOSUPPLEMENTATION MARKET - KEY MARKET DYNAMICS

5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. VISCOSUPPLEMENTATION MARKET - GLOBAL MARKET ANALYSIS

6.1. VISCOSUPPLEMENTATION - GLOBAL MARKET OVERVIEW
6.2. VISCOSUPPLEMENTATION - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. VISCOSUPPLEMENTATION MARKET - REVENUE AND FORECASTS TO 2027 - COURSE OF TREATMENT

7.1. OVERVIEW
7.2. COURSE OF TREATMENT MARKET FORECASTS AND ANALYSIS
7.3. SINGLE INJECTION
7.3.1. Overview
7.3.2. Single Injection Market Forecast and Analysis
7.4. MULTIPLE INJECTION
7.4.1. Overview
7.4.2. Multiple Injection Market Forecast and Analysis

8. VISCOSUPPLEMENTATION MARKET - REVENUE AND FORECASTS TO 2027 - ANATOMY

8.1. OVERVIEW
8.2. ANATOMY MARKET FORECASTS AND ANALYSIS
8.3. KNEE OSTEOARTHRITIS
8.3.1. Overview
8.3.2. Knee Osteoarthritis Market Forecast and Analysis
8.4. HIP OSTEOARTHRITIS
8.4.1. Overview
8.4.2. Hip Osteoarthritis Market Forecast and Analysis
8.5. ANKLE OSTEOARTHRITIS
8.5.1. Overview
8.5.2. Ankle Osteoarthritis Market Forecast and Analysis
8.6. SHOULDER OSTEOARTHRITIS
8.6.1. Overview
8.6.2. Shoulder Osteoarthritis Market Forecast and Analysis

9. VISCOSUPPLEMENTATION MARKET - REVENUE AND FORECASTS TO 2027 - END USER

9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. CLINICS
9.4.1. Overview
9.4.2. Clinics Market Forecast and Analysis
9.5. AMBULATORY SURGICAL CENTERS
9.5.1. Overview
9.5.2. Ambulatory Surgical Centers Market Forecast and Analysis

10. VISCOSUPPLEMENTATION MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS

10.1. NORTH AMERICA
10.1.1 North America Viscosupplementation Market Overview
10.1.2 North America Viscosupplementation Market Forecasts and Analysis
10.1.3 North America Viscosupplementation Market Forecasts and Analysis - By Course of Treatment
10.1.4 North America Viscosupplementation Market Forecasts and Analysis - By Anatomy
10.1.5 North America Viscosupplementation Market Forecasts and Analysis - By End User
10.1.6 North America Viscosupplementation Market Forecasts and Analysis - By Countries
10.1.6.1 United States Viscosupplementation Market
10.1.6.1.1 United States Viscosupplementation Market by Course of Treatment
10.1.6.1.2 United States Viscosupplementation Market by Anatomy
10.1.6.1.3 United States Viscosupplementation Market by End User
10.1.6.2 Canada Viscosupplementation Market
10.1.6.2.1 Canada Viscosupplementation Market by Course of Treatment
10.1.6.2.2 Canada Viscosupplementation Market by Anatomy
10.1.6.2.3 Canada Viscosupplementation Market by End User
10.1.6.3 Mexico Viscosupplementation Market
10.1.6.3.1 Mexico Viscosupplementation Market by Course of Treatment
10.1.6.3.2 Mexico Viscosupplementation Market by Anatomy
10.1.6.3.3 Mexico Viscosupplementation Market by End User
10.2. EUROPE
10.2.1 Europe Viscosupplementation Market Overview
10.2.2 Europe Viscosupplementation Market Forecasts and Analysis
10.2.3 Europe Viscosupplementation Market Forecasts and Analysis - By Course of Treatment
10.2.4 Europe Viscosupplementation Market Forecasts and Analysis - By Anatomy
10.2.5 Europe Viscosupplementation Market Forecasts and Analysis - By End User
10.2.6 Europe Viscosupplementation Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Viscosupplementation Market
10.2.6.1.1 Germany Viscosupplementation Market by Course of Treatment
10.2.6.1.2 Germany Viscosupplementation Market by Anatomy
10.2.6.1.3 Germany Viscosupplementation Market by End User
10.2.6.2 France Viscosupplementation Market
10.2.6.2.1 France Viscosupplementation Market by Course of Treatment
10.2.6.2.2 France Viscosupplementation Market by Anatomy
10.2.6.2.3 France Viscosupplementation Market by End User
10.2.6.3 Italy Viscosupplementation Market
10.2.6.3.1 Italy Viscosupplementation Market by Course of Treatment
10.2.6.3.2 Italy Viscosupplementation Market by Anatomy
10.2.6.3.3 Italy Viscosupplementation Market by End User
10.2.6.4 Spain Viscosupplementation Market
10.2.6.4.1 Spain Viscosupplementation Market by Course of Treatment
10.2.6.4.2 Spain Viscosupplementation Market by Anatomy
10.2.6.4.3 Spain Viscosupplementation Market by End User
10.2.6.5 United Kingdom Viscosupplementation Market
10.2.6.5.1 United Kingdom Viscosupplementation Market by Course of Treatment
10.2.6.5.2 United Kingdom Viscosupplementation Market by Anatomy
10.2.6.5.3 United Kingdom Viscosupplementation Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Viscosupplementation Market Overview
10.3.2 Asia-Pacific Viscosupplementation Market Forecasts and Analysis
10.3.3 Asia-Pacific Viscosupplementation Market Forecasts and Analysis - By Course of Treatment
10.3.4 Asia-Pacific Viscosupplementation Market Forecasts and Analysis - By Anatomy
10.3.5 Asia-Pacific Viscosupplementation Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Viscosupplementation Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Viscosupplementation Market
10.3.6.1.1 Australia Viscosupplementation Market by Course of Treatment
10.3.6.1.2 Australia Viscosupplementation Market by Anatomy
10.3.6.1.3 Australia Viscosupplementation Market by End User
10.3.6.2 China Viscosupplementation Market
10.3.6.2.1 China Viscosupplementation Market by Course of Treatment
10.3.6.2.2 China Viscosupplementation Market by Anatomy
10.3.6.2.3 China Viscosupplementation Market by End User
10.3.6.3 India Viscosupplementation Market
10.3.6.3.1 India Viscosupplementation Market by Course of Treatment
10.3.6.3.2 India Viscosupplementation Market by Anatomy
10.3.6.3.3 India Viscosupplementation Market by End User
10.3.6.4 Japan Viscosupplementation Market
10.3.6.4.1 Japan Viscosupplementation Market by Course of Treatment
10.3.6.4.2 Japan Viscosupplementation Market by Anatomy
10.3.6.4.3 Japan Viscosupplementation Market by End User
10.3.6.5 South Korea Viscosupplementation Market
10.3.6.5.1 South Korea Viscosupplementation Market by Course of Treatment
10.3.6.5.2 South Korea Viscosupplementation Market by Anatomy
10.3.6.5.3 South Korea Viscosupplementation Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Viscosupplementation Market Overview
10.4.2 Middle East and Africa Viscosupplementation Market Forecasts and Analysis
10.4.3 Middle East and Africa Viscosupplementation Market Forecasts and Analysis - By Course of Treatment
10.4.4 Middle East and Africa Viscosupplementation Market Forecasts and Analysis - By Anatomy
10.4.5 Middle East and Africa Viscosupplementation Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Viscosupplementation Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Viscosupplementation Market
10.4.6.1.1 South Africa Viscosupplementation Market by Course of Treatment
10.4.6.1.2 South Africa Viscosupplementation Market by Anatomy
10.4.6.1.3 South Africa Viscosupplementation Market by End User
10.4.6.2 Saudi Arabia Viscosupplementation Market
10.4.6.2.1 Saudi Arabia Viscosupplementation Market by Course of Treatment
10.4.6.2.2 Saudi Arabia Viscosupplementation Market by Anatomy
10.4.6.2.3 Saudi Arabia Viscosupplementation Market by End User
10.4.6.3 U.A.E Viscosupplementation Market
10.4.6.3.1 U.A.E Viscosupplementation Market by Course of Treatment
10.4.6.3.2 U.A.E Viscosupplementation Market by Anatomy
10.4.6.3.3 U.A.E Viscosupplementation Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Viscosupplementation Market Overview
10.5.2 South and Central America Viscosupplementation Market Forecasts and Analysis
10.5.3 South and Central America Viscosupplementation Market Forecasts and Analysis - By Course of Treatment
10.5.4 South and Central America Viscosupplementation Market Forecasts and Analysis - By Anatomy
10.5.5 South and Central America Viscosupplementation Market Forecasts and Analysis - By End User
10.5.6 South and Central America Viscosupplementation Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Viscosupplementation Market
10.5.6.1.1 Brazil Viscosupplementation Market by Course of Treatment
10.5.6.1.2 Brazil Viscosupplementation Market by Anatomy
10.5.6.1.3 Brazil Viscosupplementation Market by End User
10.5.6.2 Argentina Viscosupplementation Market
10.5.6.2.1 Argentina Viscosupplementation Market by Course of Treatment
10.5.6.2.2 Argentina Viscosupplementation Market by Anatomy
10.5.6.2.3 Argentina Viscosupplementation Market by End User

11. INDUSTRY LANDSCAPE

11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12. VISCOSUPPLEMENTATION MARKET, KEY COMPANY PROFILES

12.1. BIOVENTUS INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ANIKA THERAPEUTICS
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. SEIKAGAKU CORPORATION
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ZIMMER BIOMET
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. SMITH AND NEPHEW PLC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. FERRING B.V.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. LIFECORE BIOMEDICAL, LLC (LANDEC)
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SALIX PHARMACEUTICALS
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. FIDIA FARMACEUTICI S.P.A
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. LG LIFE SCIENCES LTD.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX

13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Bioventus Inc.
2. Anika Therapeutics
3. Seikagaku Corporation
4. Zimmer Biomet
5. Smith & Nephew PLC
6. Ferring B.V.
7. Lifecore Biomedical, LLC (Landec)
8. Salix Pharmaceuticals
9. Fidia Farmaceutici S.P.A
10. LG Life Sciences Ltd.